艾司氯胺酮在一又二分之一鼻孔-蝶窦入路垂体瘤神经内镜切除术中的应用效果

doi:10.20047/j.issn1673-7210.2023.28.27

Abstract
Figure/Table
References (28)
Related Citation (4)

Download: PDF (628 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the application effect of Esketamine on neuroendoscopic resection of pituitary tumor by one-and-a-half nostril-sphenoid sinus approach. Methods A total of 98 patients who underwent neuroendoscopic resection of pituitary tumor by one-and-a-half nostril-sphenoid sinus approach from 904th Hospital of Joint Logistic Support Force of Chinese People’s Liberation Army from March 2020 to January 2022 were selected, and they were divided into study group (49 cases) and control group (49 cases) by random number table method. In study group, Esketamine 0.5 mg/kg was injected intravenously before anesthesia induction, and 0.1 mg/(kg·h) Esketamine was pumped continuously during the operation until the end of the operation; and control group was given intravenous saline in the same way. The heart rate (HR) levels of two groups were compared before anesthesia induction (T0), immediately after tracheal intubation (T1), at the end of surgery (T2), 1 h after surgery (T3) and 3 h after surgery (T4); visual analog scale (VAS) scores of T3, T4, and 6 h after surgery (T5) were compared between two groups; the dosage of Remifentanil and Propofol were compared between the two groups; the coughing degree of two groups was compared; and the occurrence of complications during recovery period was observed in the two groups. Results There was significant difference in HR between two groups at different time points within the group (P＜0.05); at T1-T4, there were statistical significances in HR between two groups (P＜0.05). The VAS scores of two groups at different time points were compared, and the difference was statistically significant (P＜0.05); at T3-T5, the VAS scores of study group were lower than those of control group, and the differences were statistically significant (P＜0.05). The dosage of Remifentanil and Propofol in study group were lower than those in control group, and the differences were statistically significant (P＜0.05). The coughing degree of study group was lower than that of control group, and the difference was statistically significant (P＜0.05). There was no significant difference in the total incidence of complications during recovery between two groups (P＞0.05). Conclusion Esketamine is effective on neuroendoscopic resection of pituitary tumor by one-and-a-half nostril-sphenoid sinus approach, maintaining hemodynamic stability, safety and reliability.

Key words： Esketamine One-and-a-half nostril-sphenoid sinus approach Neuroendoscopic resection of pituitary tumor Anesthetic effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LIU Ting JIA Xuandong TANG Yanbin XIAO Jifeng LIAO Xingzhi▲

Cite this article:

LIU Ting JIA Xuandong TANG Yanbin XIAO Jifeng LIAO Xingzhi▲. Application effect of Esketamine on neuroendoscopic resection of pituitary tumor by one-and-a-half nostril-sphenoid sinus approach[J]. 中国医药导报, 2023, 20(28): 123-126.

URL:

https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2023.28.27 OR https://www.yiyaodaobao.com.cn/EN/Y2023/V20/I28/123

[1] 郭卉，黄萍，熊莉娜.不同经鼻-蝶窦入路神经内镜切除术治疗垂体瘤的安全性及有效性研究[J].中国医刊，2021，56（1）：56-60.
[2] 张芬芳，陈静芳，张颖，等.经鼻蝶窦入路垂体瘤切除术后颅内感染危险因素[J].中华医院感染学杂志，2021，31（14）：2174-2178.
[3] 黄伟莉，任明军，彭根英，等.经鼻蝶窦入路垂体瘤切除术后颅内感染病原学及其影响因素[J].中华医院感染学杂志，2021，31（6）：876-880.
[4] 李文松，税磊.经鼻蝶窦垂体瘤术后颅内感染的高危因素及早期动态监测血清PCT、FBG及CRP水平的临床意义[J].中国煤炭工业医学杂志，2021，24（3）：255-260.
[5] 张英，张玉琴，赵静，等.内镜下垂体瘤切除术对库欣综合征的效果观察[J].医药论坛杂志，2021，42（15）：103- 105.
[6] 汤浩，卫永旭，杨文磊，等.神经内镜下经鼻-蝶窦垂体瘤切除入路改进及效果分析[J].中华医学杂志，2018，98（37）：3021-3024.
[7] 张国栋，赵岗，师鹏强，等.神经内镜下“一侧半”经鼻-蝶窦入路切除术对高龄垂体瘤患者的疗效及术后复发的危险因素[J].中国老年学杂志，2021，41（3）：509-513.
[8] 周波，周南开.神经内镜下经鼻蝶垂体瘤切除术的常见并发症及防治[J].重庆医学，2011，40（16）：1634-1635.
[9] 杨春，刘寒玉，刘存明.艾司氯胺酮的临床应用进展[J].临床麻醉学杂志，2023，39（4）：414-417.
[10] 康艺涵，朱尤壮，秦上媛，等.艾司氯胺酮的研究进展[J].中国医师进修杂志，2021，44（5）：470-476.
[11] 郝玉娟，胡胜红，王胜斌，等.低剂量艾司氯胺酮对甲状腺切除术后苏醒期气管导管呛咳反应的影响[J].实用医学杂志，2021，37（21）：2791-2794.
[12] 中国垂体腺瘤协作组.中国垂体腺瘤外科治疗专家共识[J].中华医学杂志，2015，95（5）：324-329.
[13] 张羽冠，唐帅，薛杨，等.3种分泌型垂体瘤切除术术后躁动及恢复质量的比较[J].基础医学与临床，2020，40（10）：1399-1402.
[14] 侯莉娜，孙媛媛，姚莉娟，等.基于医护一体化的临床护理路径在垂体瘤切除术患者中的应用[J].齐鲁护理杂志，2021，27（24）：26-28.
[15] 王小慧，王丽，白延成，等.不同时间点给予纳布啡对神经内镜垂体瘤切除术患者苏醒期呛咳反应的影响[J].西部医学，2022，34（6）：829-833.
[16] 肖奎，唐协林，周良学，等.神经内镜经单鼻孔蝶窦入路治疗垂体瘤的临床疗效分析[J].中国临床医生杂志，2021，49（7）：831-833.
[17] 李永艳，刘建香，潘晓彦，等.经鼻蝶垂体瘤手术患者麻醉苏醒后不同时间饮水的效果研究[J].护士进修杂志，2022，37（17）：1628-1631.
[18] 赵曦，金毅，于砾淳，等.熵指数监测在神经内镜垂体瘤手术全身麻醉深度监测中的应用[J].现代肿瘤医学，2021，29（24）：4388-4391.
[19] 冯龙，刘耀鸿，刘琳，等.经鼻蝶窦垂体瘤切除术老年患者的麻醉管理一例[J].临床麻醉学杂志，2022，38（12）：1336-1337.
[20] 李洪超，宁林，张琦玮，等.艾司氯胺酮联合舒芬太尼在髋关节置换术中辅助镇痛的有效剂量[J].局解手术学杂志，2023，32（3）：221-224.
[21] 何睿，谢本发，易红，等.亚麻醉剂量艾司氯胺酮用于腹腔镜胆囊切除术麻醉诱导的临床疗效[J].临床和实验医学杂志，2022，21（24）：2686-2689.
[22] 林文仲，卓庆亮.不同剂量艾司氯胺酮对老年胃癌患者术后镇痛及认知功能的影响[J].中国当代医药，2022， 29（34）：151-155.
[23] 朱超秀，郑燕茹，赵志虎.艾司氯胺酮联合咪达唑仑在小儿增强CT检查中的镇静效果观察[J].中外医学研究，2022，20（26）：18-21.
[24] 龚晓毅，翁立阳，郭冬冬，等.小剂量艾司氯胺酮对无痛胃肠镜检查时丙泊酚联合瑞芬太尼麻醉效果的影响[J].中国临床研究，2022，35（1）：61-65.
[25] 朱立杰，闫战秋，吕小静，等.麻醉诱导前静注及术中持续泵入艾司氯胺酮的腹腔镜全子宫切除术患者炎性指标及术后早期疼痛情况观察[J].山东医药，2022，62（33）： 50-53.
[26] 秦勇，吴华伟，吴善武，等.经鼻蝶入路显微镜下垂体腺瘤切除术后蝶窦的变化及蝶窦炎发生的相关因素分析[J].肿瘤研究与临床，2021，33（1）：48-52.
[27] 徐乾，梁威，李鹏，等.艾司氯胺酮通过调控miR-148a- 3p/KLF4通路减轻脊髓损伤大鼠的炎症反应[J].临床麻醉学杂志，2022，38（9）：965-970.
[28] 冯兆胜，武亚芸，梁士权，等.亚麻醉剂量艾司氯胺酮用于胸腔镜肺叶切除术镇痛效果的观察[J].实用药物与临床，2022，25（12）：1103-1107.